pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-367 |
Genomic Coordinates | chr4: 112647874 - 112647941 |
Synonyms | MIRN367, hsa-mir-367, MIR367 |
Description | Homo sapiens miR-367 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-367-3p | |||||||||||||||||||||
Sequence | 44| AAUUGCACUUUAGCAAUGGUGA |65 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC12A5 | ||||||||||||||||||||
Synonyms | EIEE34, EIG14, KCC2, hKCC2 | ||||||||||||||||||||
Description | solute carrier family 12 member 5 | ||||||||||||||||||||
Transcript | NM_001134771 | ||||||||||||||||||||
Other Transcripts | NM_020708 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC12A5 | |||||||||||||||||||||
3'UTR of SLC12A5 (miRNA target sites are highlighted) |
>SLC12A5|NM_001134771|3'UTR 1 GAACCAGGACCTGCCACCCGGGCCCGAGCGCGCCCGGCCCGCGGCTCCGGAGCCCTCGCCGCGCCCCCCGCCGCTGTCAC 81 CGTTTACATACAGACCCTGTGCCCGTGTCCTGGCCCCTTACCCCGCTGCCTGAAGCCCGGAGGCCACGCCTGTTGGGGCT 161 GATTCGGAGAGGGCGCCCCGCCGCGCAGAGACCAGAGCTCCTCAGTGCCAGTTTGGCCCCTGGGTCTTCGCTGCCCTTTT 241 TCTAAGCCCGGCCTCGTCTCGCCGGAGGAGACGCTGCAATAAAGGTTGGGAGAAGGCGCGGAAAGGAGAGGAGCTGGGGC 321 CTTGGGGACCCCCAGGTAGTCCATGCGGCCCATTCCTCCCCTTCCCACTCCCGCCGCGGTCCTCGCTCTGCGCTCCTCCG 401 GCGCTGCTCCCTGGCTCCCGGCGGCCCGGAGGCCCGCGGGGTGGGAAGGCCGCGCTTGCCGTCTCCGCCGCCCCTTCTCG 481 CCGAGCCGTGGGGCGCGGGCGGCCGAGCCTATACATAGTGTACAGGAGACATCGCGTGTATTTTTAACGTCCCCATATTT 561 ATGTGACTAGAAGCGCAACAGACTTCTCGCCATAGTCGAGCTCTCCCGCTGGGGGCACTGCGGGGAGGCGAGGCCTCGGG 641 AAGCTGAATTTTCCTTGACGTCCAAGAGTTTGAGAGCGAAAGTGCTTTAGGCCCAGGCGGGGGTCGTGGCCTCGTTCCCT 721 CGACACCTCCGTCCTGCTCTCGCCTCTTCGCCCTTTCCGCGCGCCCTTGGCTTCCCACCCTCCTCTCCAGTCCTTTTCCG 801 AGATGAGGTGAGACAAGGGTCCAACTTTTCCTGGATTCGCCTCCCAGCGGACGTGAGCTTCCACTGCGGCTGCAGAGACG 881 CGAGCAACCTCTTCTCATCGGCTCTTATGCAAGTTGGGGCCAGGATAGGGGAGGGGTGCTCCTCAAGAGGAAGAAACCGA 961 GAGGCCCGCGCCCCACCGAGGAAGCCCCGCCCCGGTGCCTTCGCTGGGGAGCAGGCGTCTCTCCTCAGTCGGCTTGTCGC 1041 CTGCTCCCCGTATCCCATGGCTCCTCGCCAAAGACTGAAATTGTGGAGCTGGAGGGCGCCCCCTCCCCGGAGTTTCCTCC 1121 CTGGGACAAGTGAGGGAGGAGGGGGCCGATTCTGGTTTAGGGGCCGGACCCACTGAGAGGCCCCAGAGCCGCCCGTGATG 1201 TTCCTCCCCCGTCCCCATCTGGCAGCTCCTGTCTCGCCTGAGGGACCCAGCCGCCTTCTCCGTGCTCTGGGGCCGGGCCT 1281 CGCTGCTTAGCAGCGGCCTCTAGCTCCGTCTCCCGGGGACCTGGGCCTGAGGGAGGGCTGGAGTCGCACGCGCTTTGTCC 1361 TTAGCGCCTGTCTGCTCTCCTCTAACTAGGACCCAGGGCCTTTGGCTTCCCCAGCTCATCCTTGGCCCTTCCGCTCCACC 1441 AGCCTGGTCTGAGGCGTGCTCTGTCCTTAGAGAAGGCGCGGTGGCCGGGTTCCCTTCCCCTAGGGCACATTACTAAGGGG 1521 GTCAGGCACTGCATGCTCGTTCCAGCACCATCTGGGACTGGGTACAGTACCTCCAGCCCCAGGGCCCTGACCTGCGCACC 1601 TAGCTTGACATCTCACGCACCTCCCAGAGCTGGCGCCACTGAGTAATCCGGACCTCACCACCTCTTTTCCTTTGAGCCCA 1681 AGGCAGAGCTGGAGCTGGCGCCACCCAGACAGCGTCAGGTGTGGCTGGGGTAGGTTTGGAGGTCTGCCAGTTACACCAAG 1761 TCCCCTCTGAGATTCGATCAGGGGACTGGATAGATTCTTTCAGGTACTCAATCAGGAAGCTGGAGGTGTTAGACACCAGC 1841 CCCCTGCATCCTTCAGTAGACCTCCCTCTGAACACCACAGCCAGGTCCTGCCTTCTGGGGGCCTGAATATTCCAGAGCTG 1921 ATGTGATGGGCTGTGCAGAAGGGGGCTGTATCAACATCAATTAGGGAACCAAAGTTGCACTATCTGGGCCCAGATTGTCT 2001 GGTTGGCAAGAGCAAAGTTTCCGTTGATGAAACAGACATCCCACAACAAAAACCCAAGTTTTCTGTGCTACATGTGCAAT 2081 ATTTGTTATGAATGTTATCACAAGTCATTCATCAAGTTATCTTTATAATCACTGTAGTTAGATGTTTCATGTCCATTCAA 2161 GTGACTTTTATTCTGAGTGCAATATTTCAATAGCCTTGTAGTGATAACTAGTGTTGCTTTTGTTTTAGATGATCTATGTG 2241 CAGGGCAATGCAATGAAGTTGAAAACCCTTGTAAATAGGAGAGGTTGCAAACCAAATCAAGAGTATTTATTACTATTACT 2321 GCTATTATTATTAGGCCTGCCTTTAATTTTCAGTGTAAGTGTTCAGTATGCCGCATCCTGCCTCAGTATTGATCTTGTGT 2401 TCTTTGTGCCAATATGAAAAGGAGAGGGTTGGTTCTTTCCTTTATTGTTGAATGCTCCCATTTAATGCTTTATGGCTTTT 2481 ACTGTATTACTTTTTTAGACTCCCGTCTGCACAAAATGCAATAAAAATAATTTTATTATACCCTTAAAAAAAAAAAAAAA 2561 AAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000243964.3 | 3UTR | ACUUUUAUUCUGAGUGCAAUAUUUCAAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
255 hsa-miR-367-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT055315 | DUSP5 | dual specificity phosphatase 5 | ![]() |
![]() |
2 | 8 | ||||||
MIRT055791 | PLEKHA1 | pleckstrin homology domain containing A1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT057114 | DDIT4 | DNA damage inducible transcript 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT059663 | GATAD2B | GATA zinc finger domain containing 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT059926 | ZDHHC5 | zinc finger DHHC-type containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT061610 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT066478 | HMGA2 | high mobility group AT-hook 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT069388 | ZFYVE21 | zinc finger FYVE-type containing 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT069972 | GEMIN2 | gem nuclear organelle associated protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT074764 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT076199 | GID4 | GID complex subunit 4 homolog | ![]() |
![]() |
2 | 6 | ||||||
MIRT077512 | UBE2Z | ubiquitin conjugating enzyme E2 Z | ![]() |
![]() |
2 | 4 | ||||||
MIRT077903 | TOB1 | transducer of ERBB2, 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT082250 | MED29 | mediator complex subunit 29 | ![]() |
![]() |
2 | 4 | ||||||
MIRT082434 | CIC | capicua transcriptional repressor | ![]() |
![]() |
2 | 6 | ||||||
MIRT082474 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT082778 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 2 | ||||||
MIRT084533 | BCL2L11 | BCL2 like 11 | ![]() |
![]() |
2 | 8 | ||||||
MIRT085309 | UBXN4 | UBX domain protein 4 | ![]() |
![]() |
2 | 8 | ||||||
MIRT086365 | SSFA2 | sperm specific antigen 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT087455 | NF2 | neurofibromin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT088865 | FOXN2 | forkhead box N2 | ![]() |
![]() |
2 | 12 | ||||||
MIRT092185 | ITPR1 | inositol 1,4,5-trisphosphate receptor type 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT092326 | EDEM1 | ER degradation enhancing alpha-mannosidase like protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT093533 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | ![]() |
![]() |
2 | 6 | ||||||
MIRT096935 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | ![]() |
![]() |
2 | 8 | ||||||
MIRT097026 | MAP1B | microtubule associated protein 1B | ![]() |
![]() |
2 | 4 | ||||||
MIRT099137 | MYLIP | myosin regulatory light chain interacting protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT099905 | SOX4 | SRY-box 4 | ![]() |
![]() |
2 | 12 | ||||||
MIRT102289 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | ![]() |
![]() |
2 | 10 | ||||||
MIRT102507 | KLHDC10 | kelch domain containing 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT102891 | INSIG1 | insulin induced gene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT109188 | VMA21 | VMA21, vacuolar ATPase assembly factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT124567 | PRRC2B | proline rich coiled-coil 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT135568 | SPRYD4 | SPRY domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT161135 | SLC25A36 | solute carrier family 25 member 36 | ![]() |
![]() |
2 | 6 | ||||||
MIRT163995 | KIAA1109 | KIAA1109 | ![]() |
![]() |
2 | 4 | ||||||
MIRT164689 | RNF4 | ring finger protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT167705 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT178956 | USP28 | ubiquitin specific peptidase 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT185717 | ARNTL2 | aryl hydrocarbon receptor nuclear translocator like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT186264 | TCEB3 | elongin A | ![]() |
![]() |
2 | 2 | ||||||
MIRT186537 | TWF1 | twinfilin actin binding protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT186628 | COX20 | COX20, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 8 | ||||||
MIRT189373 | TXLNA | taxilin alpha | ![]() |
![]() |
2 | 4 | ||||||
MIRT197013 | EIF1 | eukaryotic translation initiation factor 1 | ![]() |
![]() |
2 | 10 | ||||||
MIRT206437 | YIPF4 | Yip1 domain family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT211228 | FGF2 | fibroblast growth factor 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT214529 | C5ORF24 | chromosome 5 open reading frame 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT216034 | IL6ST | interleukin 6 signal transducer | ![]() |
![]() |
2 | 10 | ||||||
MIRT218084 | TULP4 | tubby like protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT242418 | CCDC113 | coiled-coil domain containing 113 | ![]() |
![]() |
2 | 2 | ||||||
MIRT243162 | SOX11 | SRY-box 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT250943 | CDK5R1 | cyclin dependent kinase 5 regulatory subunit 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT253350 | ZNF417 | zinc finger protein 417 | ![]() |
![]() |
2 | 2 | ||||||
MIRT271968 | ARF1 | ADP ribosylation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT273214 | ZNF695 | zinc finger protein 695 | ![]() |
![]() |
2 | 4 | ||||||
MIRT296114 | SLC12A5 | solute carrier family 12 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT301711 | TEF | TEF, PAR bZIP transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT316477 | ARID1B | AT-rich interaction domain 1B | ![]() |
![]() |
2 | 6 | ||||||
MIRT322174 | CLN8 | CLN8, transmembrane ER and ERGIC protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT341538 | CNIH1 | cornichon family AMPA receptor auxiliary protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT356062 | SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443579 | PPIC | peptidylprolyl isomerase C | ![]() |
![]() |
2 | 2 | ||||||
MIRT448825 | FKBP1A | FK506 binding protein 1A | ![]() |
![]() |
2 | 4 | ||||||
MIRT451494 | FOPNL | FGFR1OP N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT452694 | MDM2 | MDM2 proto-oncogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT453167 | CNOT4 | CCR4-NOT transcription complex subunit 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT454588 | SLC33A1 | solute carrier family 33 member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT455794 | TAF8 | TATA-box binding protein associated factor 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT456010 | CYP2C19 | cytochrome P450 family 2 subfamily C member 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456044 | KIAA1586 | KIAA1586 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456763 | TMEM239 | transmembrane protein 239 | ![]() |
![]() |
2 | 4 | ||||||
MIRT458068 | NLRP9 | NLR family pyrin domain containing 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459230 | MRPS21 | mitochondrial ribosomal protein S21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459534 | MFF | mitochondrial fission factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT459759 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT460236 | TNFRSF13C | TNF receptor superfamily member 13C | ![]() |
![]() |
2 | 2 | ||||||
MIRT461104 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT462924 | ZNRF3 | zinc and ring finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463476 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT463516 | ZBTB8B | zinc finger and BTB domain containing 8B | ![]() |
![]() |
2 | 4 | ||||||
MIRT465503 | TOR1B | torsin family 1 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT469525 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT470079 | PTGES2 | prostaglandin E synthase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471581 | PARD6B | par-6 family cell polarity regulator beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT473451 | MCOLN2 | mucolipin 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT475882 | H3F3C | H3 histone family member 3C | ![]() |
![]() |
2 | 10 | ||||||
MIRT475915 | H3F3B | H3 histone family member 3B | ![]() |
![]() |
2 | 8 | ||||||
MIRT476195 | GOLGA8A | golgin A8 family member A | ![]() |
![]() |
2 | 10 | ||||||
MIRT476318 | GM2A | GM2 ganglioside activator | ![]() |
![]() |
2 | 2 | ||||||
MIRT476676 | FUT11 | fucosyltransferase 11 | ![]() |
![]() |
2 | 10 | ||||||
MIRT478368 | DDI2 | DNA damage inducible 1 homolog 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479545 | CDC5L | cell division cycle 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT481024 | BAZ2B | bromodomain adjacent to zinc finger domain 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT491009 | ATF7IP | activating transcription factor 7 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT493168 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494345 | CASKIN1 | CASK interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499087 | ZDHHC21 | zinc finger DHHC-type containing 21 | ![]() |
![]() |
2 | 6 | ||||||
MIRT500029 | ABCF2 | ATP binding cassette subfamily F member 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT501298 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT503124 | BCL11B | B-cell CLL/lymphoma 11B | ![]() |
![]() |
2 | 8 | ||||||
MIRT503301 | GTF2A1 | general transcription factor IIA subunit 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT504328 | ASGR2 | asialoglycoprotein receptor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT504471 | EID2B | EP300 interacting inhibitor of differentiation 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT504655 | RPL9 | ribosomal protein L9 | ![]() |
![]() |
2 | 6 | ||||||
MIRT505331 | TMF1 | TATA element modulatory factor 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT505732 | SERTAD3 | SERTA domain containing 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT505827 | RSBN1 | round spermatid basic protein 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT506004 | PURG | purine rich element binding protein G | ![]() |
![]() |
2 | 8 | ||||||
MIRT506308 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT506806 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 6 | ||||||
MIRT507119 | GOLGA8B | golgin A8 family member B | ![]() |
![]() |
2 | 6 | ||||||
MIRT507353 | FAM129A | family with sequence similarity 129 member A | ![]() |
![]() |
2 | 6 | ||||||
MIRT507591 | DDX3X | DEAD-box helicase 3, X-linked | ![]() |
![]() |
2 | 4 | ||||||
MIRT507674 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT507703 | CNOT2 | CCR4-NOT transcription complex subunit 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT508012 | BCAT1 | branched chain amino acid transaminase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510439 | ZIC5 | Zic family member 5 | ![]() |
![]() |
2 | 6 | ||||||
MIRT510539 | XKR7 | XK related 7 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510600 | TPPP | tubulin polymerization promoting protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT511060 | NRAS | NRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 4 | ||||||
MIRT511855 | GOLGA8J | golgin A8 family member J | ![]() |
![]() |
2 | 6 | ||||||
MIRT511865 | GOLGA8I | golgin A8 family member I, pseudogene | ![]() |
1 | 3 | |||||||
MIRT512570 | CTDSPL | CTD small phosphatase like | ![]() |
![]() |
2 | 2 | ||||||
MIRT512708 | ZNF134 | zinc finger protein 134 | ![]() |
![]() |
2 | 6 | ||||||
MIRT513177 | MOAP1 | modulator of apoptosis 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT513783 | PAWR | pro-apoptotic WT1 regulator | ![]() |
![]() |
2 | 6 | ||||||
MIRT515099 | IRGQ | immunity related GTPase Q | ![]() |
![]() |
2 | 2 | ||||||
MIRT515481 | INCENP | inner centromere protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT517416 | BMP8A | bone morphogenetic protein 8a | ![]() |
![]() |
2 | 2 | ||||||
MIRT518754 | C1orf35 | chromosome 1 open reading frame 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519780 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 4 | ||||||
MIRT519865 | ZFP62 | ZFP62 zinc finger protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT520510 | TRAM2 | translocation associated membrane protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT521068 | SLC25A32 | solute carrier family 25 member 32 | ![]() |
![]() |
2 | 6 | ||||||
MIRT526912 | ZNF772 | zinc finger protein 772 | ![]() |
![]() |
2 | 6 | ||||||
MIRT527134 | GULP1 | GULP, engulfment adaptor PTB domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527867 | SLC39A14 | solute carrier family 39 member 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528404 | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532956 | ZNF24 | zinc finger protein 24 | ![]() |
![]() |
2 | 4 | ||||||
MIRT533021 | ZFC3H1 | zinc finger C3H1-type containing | ![]() |
![]() |
2 | 4 | ||||||
MIRT533191 | WASL | Wiskott-Aldrich syndrome like | ![]() |
![]() |
2 | 6 | ||||||
MIRT534191 | SLC7A11 | solute carrier family 7 member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534961 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT536396 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT537046 | GRAMD4 | GRAM domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537125 | GOLGA3 | golgin A3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT537183 | GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT537652 | ERGIC2 | ERGIC and golgi 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT538632 | CCSER2 | coiled-coil serine rich protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT539231 | ANP32E | acidic nuclear phosphoprotein 32 family member E | ![]() |
![]() |
2 | 6 | ||||||
MIRT540099 | NPY4R | neuropeptide Y receptor Y4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540998 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 4 | ||||||
MIRT541468 | AURKA | aurora kinase A | ![]() |
![]() |
2 | 2 | ||||||
MIRT542680 | SESN3 | sestrin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542757 | PRRG4 | proline rich and Gla domain 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542863 | NUCKS1 | nuclear casein kinase and cyclin dependent kinase substrate 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542925 | HOXC8 | homeobox C8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543747 | SZRD1 | SUZ RNA binding domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544404 | ZSCAN12 | zinc finger and SCAN domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544583 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT544662 | MED19 | mediator complex subunit 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545251 | GTF2E1 | general transcription factor IIE subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545261 | TRIM36 | tripartite motif containing 36 | ![]() |
![]() |
2 | 4 | ||||||
MIRT545744 | UHRF1BP1 | UHRF1 binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545999 | WDR81 | WD repeat domain 81 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546038 | VPS4B | vacuolar protein sorting 4 homolog B | ![]() |
![]() |
2 | 2 | ||||||
MIRT547170 | PDZD8 | PDZ domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547273 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547729 | KIF5B | kinesin family member 5B | ![]() |
![]() |
2 | 2 | ||||||
MIRT548127 | GATA6 | GATA binding protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548203 | FNIP1 | folliculin interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548756 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549641 | ZNF75A | zinc finger protein 75a | ![]() |
![]() |
2 | 2 | ||||||
MIRT549684 | ZNF598 | zinc finger protein 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550197 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT550340 | IPP | intracisternal A particle-promoted polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT550536 | MYZAP | myocardial zonula adherens protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT550975 | TOR4A | torsin family 4 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT551221 | CIDEC | cell death inducing DFFA like effector c | ![]() |
![]() |
2 | 2 | ||||||
MIRT551355 | AGBL5 | ATP/GTP binding protein like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551571 | LETM1 | leucine zipper and EF-hand containing transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552277 | RAB3D | RAB3D, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT552661 | ZADH2 | zinc binding alcohol dehydrogenase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT553081 | UCK2 | uridine-cytidine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT553753 | TBC1D8 | TBC1 domain family member 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554030 | SPCS3 | signal peptidase complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554099 | SMU1 | DNA replication regulator and spliceosomal factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT554155 | SLX4 | SLX4 structure-specific endonuclease subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT554815 | REL | REL proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT555522 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555597 | PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase type 1 gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT555632 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT555679 | PGAM4 | phosphoglycerate mutase family member 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT555827 | PAX9 | paired box 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555868 | PAIP1 | poly(A) binding protein interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555939 | NUP43 | nucleoporin 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555994 | NFYB | nuclear transcription factor Y subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT556340 | MAP2K4 | mitogen-activated protein kinase kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556432 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556585 | LHFPL2 | LHFPL tetraspan subfamily member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556801 | KIAA1958 | KIAA1958 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558047 | EXOC5 | exocyst complex component 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558697 | CLTA | clathrin light chain A | ![]() |
![]() |
2 | 2 | ||||||
MIRT559191 | BMPR1A | bone morphogenetic protein receptor type 1A | ![]() |
![]() |
2 | 4 | ||||||
MIRT559639 | AKAP10 | A-kinase anchoring protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559707 | AEN | apoptosis enhancing nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT560673 | SRFBP1 | serum response factor binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560990 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562170 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562275 | GNAQ | G protein subunit alpha q | ![]() |
![]() |
2 | 2 | ||||||
MIRT563624 | ZNF277 | zinc finger protein 277 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563815 | FMN1 | formin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564096 | TLR3 | toll like receptor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565320 | TMEM41A | transmembrane protein 41A | ![]() |
![]() |
2 | 2 | ||||||
MIRT565986 | RNF44 | ring finger protein 44 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566047 | REV3L | REV3 like, DNA directed polymerase zeta catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT568236 | C11orf24 | chromosome 11 open reading frame 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568310 | BAK1 | BCL2 antagonist/killer 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572376 | ATOX1 | antioxidant 1 copper chaperone | ![]() |
![]() |
2 | 2 | ||||||
MIRT574822 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609212 | PELP1 | proline, glutamate and leucine rich protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT616217 | RBM27 | RNA binding motif protein 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629087 | FASLG | Fas ligand | ![]() |
![]() |
2 | 2 | ||||||
MIRT632124 | FKBP9 | FK506 binding protein 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632576 | POLQ | DNA polymerase theta | ![]() |
![]() |
2 | 2 | ||||||
MIRT634799 | ENTHD1 | ENTH domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636553 | ESRP1 | epithelial splicing regulatory protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640977 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653875 | SH2B3 | SH2B adaptor protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655598 | OTUD7B | OTU deubiquitinase 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT659764 | CCDC171 | coiled-coil domain containing 171 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660744 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT681037 | AAED1 | AhpC/TSA antioxidant enzyme domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682305 | RBM28 | RNA binding motif protein 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682573 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686217 | ZNF267 | zinc finger protein 267 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687209 | PLXNA3 | plexin A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690630 | LAX1 | lymphocyte transmembrane adaptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692419 | AGMAT | agmatinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT694437 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700725 | PNO1 | partner of NOB1 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT701549 | NARF | nuclear prelamin A recognition factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT704379 | DAND5 | DAN domain BMP antagonist family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707935 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | ![]() |
![]() |
2 | 2 | ||||||
MIRT709939 | MRPS16 | mitochondrial ribosomal protein S16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711371 | MED7 | mediator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712327 | PER2 | period circadian clock 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714515 | SHE | Src homology 2 domain containing E | ![]() |
![]() |
2 | 2 | ||||||
MIRT715520 | G2E3 | G2/M-phase specific E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT724294 | OSMR | oncostatin M receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT725358 | MUC21 | mucin 21, cell surface associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT732242 | KLF4 | Kruppel like factor 4 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT735384 | SPAG5 | sperm associated antigen 5 | ![]() |
![]() |
![]() |
3 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|